| Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients (NCT04321993) | Lisa Barrett | 2020-04-17 |
| Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19 (NCT04358549) | Fujifilm Pharmaceuticals U.S.A., Inc. | 2020-04-17 |
| Trial of Hydroxychloroquine In Covid-19 Kinetics (NCT04353271) | University of South Alabama | 2020-04-17 |
| CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients (NCT04364737) | NYU Langone Health | 2020-04-17 |
| Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection (NCT04349098) | Karyopharm Therapeutics Inc | 2020-04-17 |
| Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection (NCT04335552) | Duke University | 2020-04-17 |
| Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy (NCT04238793) | Kolon Life Science | 2020-04-16 |
| Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) (NCT04351724) | Medical University of Vienna | 2020-04-16 |
| Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 (NCT04344457) | Perseverance Research Center, LLC | 2020-04-16 |
| Effect of Tramadol Versus Morphine on PD1 and PD1-ligand in Patients With Chronic Cancer Pain (NCT04589494) | Assiut University | 2020-04-16 |
| Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer (NCT04230954) | University of South Alabama | 2020-04-16 |
| Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 (NCT04347226) | Columbia University | 2020-04-16 |
| Effects of Vivatlac Baby on Crying Behavior of Colicky Babies (NCT04487834) | The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz | 2020-04-16 |
| Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation (NCT04357782) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2020-04-16 |
| CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort (NCT04346797) | Assistance Publique - Hôpitaux de Paris | 2020-04-16 |
| Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) (NCT04352608) | Sinovac Research and Development Co., Ltd. | 2020-04-16 |
| Treatment for COVID-19 in High-Risk Adult Outpatients (NCT04354428) | University of Washington | 2020-04-16 |
| Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19 (NCT04347239) | CytoDyn, Inc. | 2020-04-16 |
| Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation (NCT04322890) | Hunan Province Tumor Hospital | 2020-04-16 |
| Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy (NCT03965689) | National Cancer Institute (NCI) | 2020-04-16 |
| Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer (NCT04258150) | Herlev Hospital | 2020-04-16 |
| Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Breast Cancer Patients (NCT04199520) | Henan Cancer Hospital | 2020-04-15 |
| Convalescent Plasma for the Treatment of COVID-19 (NCT04389710) | Thomas Jefferson University | 2020-04-15 |
| Treating COVID-19 With Hydroxychloroquine (TEACH) (NCT04369742) | NYU Langone Health | 2020-04-15 |
| Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort. (NCT04343144) | Assistance Publique - Hôpitaux de Paris | 2020-04-15 |
| suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) (NCT04357366) | Hellenic Institute for the Study of Sepsis | 2020-04-15 |
| CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer (NCT04310774) | Peking Union Medical College Hospital | 2020-04-15 |
| Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection (NCT04333914) | Centre Leon Berard | 2020-04-15 |
| Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients (NCT04475120) | University of Rome Tor Vergata | 2020-04-15 |
| Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort (NCT04344782) | Assistance Publique - Hôpitaux de Paris | 2020-04-15 |
| A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients (NCT03976076) | Bio-Pharm Solutions Co., Ltd. | 2020-04-15 |
| Evaluation of RC28-E Injection in Wet Age-related Macular Degeneration (NCT04270669) | RemeGen Co., Ltd. | 2020-04-15 |
| Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort (NCT04345991) | Assistance Publique - Hôpitaux de Paris | 2020-04-15 |
| A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) (NCT04281472) | argenx | 2020-04-15 |
| Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia (NCT04329650) | Judit Pich Martínez | 2020-04-15 |
| A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) (NCT04351243) | Kinevant Sciences GmbH | 2020-04-15 |
| COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1 (NCT04356508) | Dr Gerry Gin Wai Kwok | 2020-04-14 |
| Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm (NCT04355247) | Auxilio Mutuo Cancer Center | 2020-04-14 |
| A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes (NCT04378920) | Institut de cancérologie Strasbourg Europe | 2020-04-14 |
| Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy (NCT04082520) | Mayo Clinic | 2020-04-14 |
| A Study of Supaglutide in Chinese Type 2 Diabetes Patients (NCT04314622) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2020-04-14 |
| Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers (NCT04345653) | Hackensack Meridian Health | 2020-04-14 |
| A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors (NCT04175847) | RemeGen Co., Ltd. | 2020-04-14 |
| A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer (NCT04152889) | RenJi Hospital | 2020-04-14 |
| Oral 25-hydroxyvitamin D3 and COVID-19 (NCT04386850) | Tehran University of Medical Sciences | 2020-04-14 |
| Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 (NCT04435808) | University of New Mexico | 2020-04-14 |
| Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) (NCT04344431) | Direction Centrale du Service de Santé des Armées | 2020-04-14 |
| PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors (NCT05357196) | SciClone Pharmaceuticals | 2020-04-13 |
| A Study of RC18 Administered Subcutaneously to Subjects With Primary IgA(Immunoglobulin A) Nephropathy (NCT04291781) | RemeGen Co., Ltd. | 2020-04-13 |
| Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) (NCT04357808) | Maria del Rosario Garcia de Vicuña Pinedo | 2020-04-13 |
| COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma (NCT04357106) | Centro de Hematología y Medicina Interna | 2020-04-13 |
| Losartan for Patients With COVID-19 Requiring Hospitalization (NCT04312009) | University of Minnesota | 2020-04-13 |
| A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma (NCT04822805) | First People's Hospital of Hangzhou | 2020-04-13 |
| A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification (NCT04191889) | Sun Yat-sen University | 2020-04-13 |
| Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease (NCT04617847) | Wave Life Sciences USA, Inc. | 2020-04-13 |
| A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) (NCT04341389) | Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China | 2020-04-12 |
| Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19. (NCT04348695) | Fundación de investigación HM | 2020-04-12 |
| Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO (NCT04341870) | Assistance Publique - Hôpitaux de Paris | 2020-04-11 |
| The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol (NCT04349410) | The Camelot Foundation | 2020-04-11 |
| Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) (NCT04345861) | University Hospital, Montpellier | 2020-04-11 |
| Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) (NCT04341116) | I-Mab Biopharma US Limited | 2020-04-11 |
| Sarilumab for Patients With Moderate COVID-19 Disease (NCT04359901) | Westyn Branch-Elliman | 2020-04-10 |
| A Single-arm, Open-label, Multi-center Phase II Clinical Study to Evaluate the Safety and Efficacy of Toripalimab Injection (JS001) Combined With Bevacizumab as the First-line Therapy for Advanced Hepatocellular Carcinoma (HCC) (NCT04605796) | Shanghai Junshi Bioscience Co., Ltd. | 2020-04-10 |
| Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) (NCT04390178) | Joakim Dillner | 2020-04-10 |
| A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection (NCT04342663) | Washington University School of Medicine | 2020-04-10 |
| The Effect of Intraperitoneal Bupivacaine Versus Bupivacaine With Neostigmine on Pain in Laparoscopic Cholecystectomy (NCT04244097) | Kasr El Aini Hospital | 2020-04-10 |
| Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors (NCT04343573) | Memorial Sloan Kettering Cancer Center | 2020-04-10 |
| TOFAcitinib in SARS-CoV2 Pneumonia (NCT04332042) | Università Politecnica delle Marche | 2020-04-10 |
| Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus (NCT04441658) | Shanghai East Hospital | 2020-04-10 |
| Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration (NCT04243954) | Fujian Cancer Hospital | 2020-04-10 |
| Anlotinib Treatment in Steroid Depenent/Refractory cGVHD (NCT04232397) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2020-04-10 |
| Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors (NCT04284488) | Ascentage Pharma Group Inc. | 2020-04-10 |
| A Phase II Study of Atezolizumab in Combination With Bevacizumab, Carboplatin or Cisplatin, and Pemetrexed for EGFR-mutant Metastatic Non-small Cell Lung Cancer Patients After Failure of EGFR Tyrosine Kinase Inhibitors. (NCT04147351) | National Taiwan University Hospital | 2020-04-10 |
| Convalescent Plasma in the Treatment of COVID 19 (NCT04343261) | Trinity Health Of New England | 2020-04-10 |
| Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 (NCT04045717) | Universitaire Ziekenhuizen KU Leuven | 2020-04-10 |
| Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19 (NCT04344236) | NYU Langone Health | 2020-04-09 |
| INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer (NCT04116073) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-04-09 |
| Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2 (NCT04081220) | The University of Texas Health Science Center at San Antonio | 2020-04-09 |
| Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel) (NCT05322889) | Dr. Frank Behrens | 2020-04-09 |
| Losartan for Patients With COVID-19 Not Requiring Hospitalization (NCT04311177) | University of Minnesota | 2020-04-09 |
| An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial (NCT04343768) | Shahid Beheshti University of Medical Sciences | 2020-04-09 |
| Checkpoint Blockade in COVID-19 Pandemic (NCT04335305) | MedSIR | 2020-04-09 |
| The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) (NCT04329923) | Ravi Amaravadi, MD | 2020-04-09 |
| A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT03992339) | Antengene Corporation | 2020-04-09 |
| Double Therapy With IFN-beta 1b and Hydroxychloroquine (NCT04350281) | The University of Hong Kong | 2020-04-09 |
| Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection (NCT04343755) | Hackensack Meridian Health | 2020-04-09 |
| Alectinib in Combination With Bevacizumab in ALK Positive NSCLC (NCT03779191) | Instituto Nacional de Cancerologia de Mexico | 2020-04-08 |
| A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 (NCT04347031) | Burnasyan Federal Medical Biophysical Center | 2020-04-08 |
| CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection (NCT04341584) | Assistance Publique - Hôpitaux de Paris | 2020-04-08 |
| Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) (NCT04342182) | Erasmus Medical Center | 2020-04-08 |
| Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection (NCT04342650) | Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | 2020-04-08 |
| Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer (NCT03983395) | Ichnos Sciences SA | 2020-04-08 |
| Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial) (NCT04268550) | SWOG Cancer Research Network | 2020-04-08 |
| Cardiovascular Effects of COVID-19 (NCT04365699) | NYU Langone Health | 2020-04-08 |
| Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B) (NCT04285346) | Marinus Pharmaceuticals | 2020-04-08 |
| The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma (NCT04356872) | Fudan University | 2020-04-08 |
| A Study of Auxora in Patients With Severe COVID-19 Pneumonia (NCT04345614) | CalciMedica, Inc. | 2020-04-08 |
| Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial (NCT06654570) | Helsinki University Central Hospital | 2020-04-08 |
| Induction FLOT With CROSS CRT for Esophageal Cancer (NCT04028167) | University of Colorado, Denver | 2020-04-08 |
| PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers (NCT04209595) | National Cancer Institute (NCI) | 2020-04-08 |